SK Life Science, Inc., a global leader in treatments for central nervous system (CNS) disorders and a subsidiary of SK Biopharmaceuticals Co., Ltd., will present new data on cenobamate, an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback